The CCR5 receptor is not some systemic poison. The seeming efficacy of leronlimab appears to be a magic key effect that hits the receptor just right with no side effects. Honestly, this appears true but is VERY hard to believe, and I completely understand the initial skepticism by legislative authorities.>>
____________________
Leronlimab does not have to hit CCR5 receptor to save people. It has three more MOAs to do this. Not hard to believe at all if you know this.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.